Find Moving Blanket , Paint Felt Roll, Agriculture Nonwoven Fabric on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > First aid kit > SARS-CoV-2 IgM/IgG Duo Rapid Antibody Test Kit

SARS-CoV-2 IgM/IgG Duo Rapid Antibody Test Kit

SARS-CoV-2 IgM/IgG Duo Rapid Antibody Test Kit

    Min. Order: 10000 Piece/Pieces
    Packaging: export standard
    Productivity: 10000000000000 pcs/year
    Brand: Uni-medica
    Transportation: Ocean,Land,Air,Express
    Place of Origin: China
    Supply Ability: 10000000000000 pcs/year
    Certificate: CE/SGS
    HS Code: 38220090
    Port: Shenzhen,Guangzhou,Hongkong

Basic Info

Model No.: R042

Product Description

This SARS-CoV-2 IgM/IgG Duo Test is a lateral flow chromatography immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, sodium citrate and lithium heparin) or finger stick whole blood, venous whole blood specimens from patients suspected of COVID-19 infection by a healthcare provider. The SARS-CoV-2 IgM/IgG Duo Test is an aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests.
Results from the SARS-CoV-2 IgM/IgG Duo Test should not be used as the sole basis for diagnosis.
Testing is limited to qualified laboratories. Results are for the detection of SARS-CoV-2 antibodies. IgM antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, although levels over the course of infection are not well characterized. IgG antibodies to SARS-CoV-2 become detectable later following infection. Positive results for both IgG and IgM could occur after infection and can be indicative of acute or recent infection.
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. IgM
antibodies may not be detected in the first few days of infection; the sensitivity of the SARS-CoV-2 IgM/IgG Duo Test early after infection is unknown.
False positive results for IgM and IgG antibodies may occur due to cross-reactivity from pre-existing antibodies or other possible causes.
At this time, it is unknown for how long IgM or IgG antibodies may persist following infection.
This is for prescription use only and for in vitro diagnostic use only.

Uni-medica always provides high quality and stable quality IVD products to all customers from all over the world.

SARS-CoV-2 antibody test kit_1SARS-CoV-2 antibody test kit_2CE-antibody_1CE-antibody_2NMPA certificateMedical Device Production License_1Export White listcustomers

Shenzhen Uni-medica Technology Co.,Ltd

 Shenzhen Uni-medica Technology Co., Ltd (Uni-medica) is a national high-tech enterprise. It has established cooperation and jointly performed a number of scientific research projects with the Hong Kong University of Science and Technology, Shenzhen University and Chinese Academy of Sciences. Uni-medica was also selected as one of the top 100 new Chinese innovative enterprises. The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R&D and industrialization of molecular diagnostic products aiming at prevention and control of infectious diseases and genetic diseases. Uni-medica provides total solution of accurate diagnosis of infectious diseases and genetic diseases based on multi-omics technologies, including multiplex PCR, NGS technology and flow cytometry. Uni-medica is qualified by ISO 13485 and CFDA quality control system. The pathogen molecular detection products are daily used in hundreds of hospitals, Centers for Disease Control and Prevention and Quarantine Laboratories throughout the country, providing strong support for prevention and control of infectious diseases.

Company Info

  • Company Name: Shenzhen Uni-medica Technology Co.,Ltd
  • Representative: Wang yan Pin
  • Product/Service: Disposable virus sampling tube , Nucleic acid extraction kits , RT-PCR test kits , One-Step method test solution of COVID-19 , Automatic test solution of COVID-19 , Nucleic acid extractors
  • Capital (Million US $): 5,000,000
  • Year Established: 2011
  • Total Annual Sales Volume (Million US $): US$10 Million - US$50 Million
  • Export Percentage: 51% - 60%
  • Total Annual Purchase Volume (Million US $): US$5 Million - US$10 Million
  • No. of Production Lines: 5
  • No. of R&D Staff: 21 -30 People
  • No. of QC Staff: 5 -10 People
  • OEM Services Provided: yes
  • Factory Size (Sq.meters): 3,000-5,000 square meters
  • Factory Location: 2nd Floor, No.6 Building, Xili Liuxian Culture Park, Nanshan District, Shenzhen City, Guangdong Province, China
  • Contact Person: Mr. Jack
  • Tel: +86-755-86502782
Email to this supplier
  • *Subject:
  • To:

  • *Messages:
    Your message must be between 20-8000 characters